But Jovic’s bad season in Madrid, with which he has only been able to score two goals in 24 games, coupled with the damage done to his image that broke the quarantine to travel to Serbia, It has sparked a wave of negative comments about the gunners’ possible signing of the forward. On the one hand, the fans are clear: a survey in the main fans’ forum of the team recommended their non-signing by 75-25% … But there is more. It was the tabloid The Sun the one who gave the hint a few days ago. He strongly reported the interest of Arteta in seizing the services of Jovic. “Arsenal are saving 50 million pounds (55 euros) to undertake the signing of Jovic this summer.” The Serbian takes a season to forget in the Real Madrid, who signed him, from Eintracht, for 60 million euros. In radio and television programs there are ex-players of high caliber who have also demonstrated. It is a matter of discussion, therefore, in the media. The mythical gunner player, Sol Campell, is clear: “If it can fit into Arsenal’s game system? I do not think so. I see a lot of Spanish football, I saw Jovic and I don’t think he would fit into our club. Simply, Zidane doesn’t like it either. ” Ferdinand also wanted to give his point of view: “He is someone who has done nothing at Real Madrid, but the potential he has shown at Eintracht has made him a player with high opinion. Another thing is what happens when a player goes to a big club, so it shouldn’t be confused. “At the moment in London they don’t seem to like Jovic. These are not good days for the Serbian.
ShareEmailPrint To learn more, read: Posted on September 12, 2012March 31, 2017By: Suzy Sacher and Paula Nersesian, John Snow, Inc. Center for Health LogisticsClick to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Reddit (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window)This post is part of a blog series on maternal health commodities. To view the entire series, click here.To improve women’s health, supply chains for essential health products must be able to deliver medicines and supplies reliably to women when and where they need them.Ensuring maternal health product availability requires well-functioning health supply chains and health staff who are trained to correctly forecast requirements, procure products on time, manage inventory, monitor supplies, maintain storage facilities, and distribute products securely. Along with these supply chain requirements, product availability depends on adequate financing, strong service delivery, coordinated efforts, and supportive policies.Maternal health products, particularly magnesium sulfate, misoprostol, and oxytocin, are commonly classified as essential medicines. Unfortunately, that classification doesn’t mean that they are always available when they’re needed. Because they require special packaging (misoprostol is sensitive to humidity) and complementary supplies (magnesium sulfate and oxytocin are injectables), there are additional challenges getting these products to the women who need them.Here are a few examples of supply chain constraints for misoprostol, magnesium sulfate, and oxytocin—Forecasts of product need are impreciseExisting vaccine cold chains are not designed to accommodate oxytocinWeak infrastructure and weak supply chains at the “last mile” make distribution down to households and peripheral health facilities difficultWeak regulation enables counterfeit, substandard, and unregistered medicines to reach local marketplaces.These constraints and others contribute to a challenging environment for ensuring that maternal health medicines are consistently available. But they can be overcome.Here are a few options for intervention—Strengthen the Supply ChainIncreasing procurement quantities alone is not enough.Supply chain capacity building activities may include training initiatives (including pre-service training), supervision, and mentoring. Community health workers and birth attendants must be included since they are often a woman’s key health provider when these products are needed.Increase Financial CommitmentsAdvocate for adequately funded government budget line items for maternal health products, and monitor spending. These line items and monitoring measures can increase accountability and promote government spending on life-saving products.Expand Service DeliveryEnsure that the dispensing/prescribing roles for service providers are appropriate and understood throughout the system. Confusion over who is allowed to administer which products often means that women do not receive the care they need. Care providers need clear guidance on what medicines they are allowed to administer.Improve CoordinationInclude maternal health supply issues on the agenda of coordinating committees. Existing committees can support product availability. Key partners such as central medical stores, nongovernmental organizations, donors, UN organizations, pharmacies, manufacturers, civil society organizations, and Ministries of Health, Finance, and Planning can initiate and influence action and change. Committees can also monitor supply issues and coordinate funding sources and procurement.Establish PoliciesInclude indicators to monitor maternal health supplies in key health policies. Monitoring the availability and use of maternal health medicines raises their profile and allows policy makers to evaluate policy implementation and ensure that their policies translate into action.Investing in developing strong supply chains and building supportive environments will ensure that maternal health medicines are available and used to save women’s lives. This is surely an investment worth making.Share this: